Anthera Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

View All

Latest Posts

About This Stock More About This Stock
Anthera's Blisibimod Positive In Phase II Extension Study
Article By: Zacks Investment Research
Tuesday, August 29, 2017 1:43 PM EDT
Anthera Pharmaceuticals, Inc. announced positive top-line data from the extension of a phase II BRIGHT-SC study, evaluating key pipeline candidate, blisibimod for treatment of patients with IgA nephropathy (IgAN).
In this article: ANTH Also: LLY, ACAD, ADRO
Read
Return On Invested Capital: The Best And Worst
Article By: David Trainer
Monday, April 25, 2016 1:53 PM EDT
ROIC is the best measure of corporate performance and the primary driver of stock prices. We show the companies with the highest and lowest ROIC.
In this article: EDU, TXMD, CRDS, ANTH, AAPL, CHKP, UBNT, VEEV, MBVX, RSPI
Read
10 Top U.S. Stocks To Keep Up The 1H Winning Streak
Article By: Sweta Killa
Tuesday, June 30, 2015 8:14 AM EDT
Given the increased confidence in the U.S. economy as well as a delayed Fed rate hike, the stock market should continue to surge. Our choice of stocks will also, hopefully, be high fliers with above-market returns in the second half.
In this article: NPTN, ANTH, OXM, NTDOY, CYBR, INSY, AMBA Also: SPY, DIA, QQQ, IWM
Read
3 Biotech Stocks Under $10 With Amazing Growth Prospects
Article By: Zacks Investment Research
Wednesday, April 15, 2015 12:03 PM EDT
The biotech sector is witnessing changing dynamics with the focus shifting from large caps to smaller companies with high growth potential.
In this article: GERN, HSP, PFE, GILD, AMGN, ESRX, NVS, JNJ, ABBV, PCYC, ANTH
Read
Anthera Pharmaceuticals Inc (ANTH) Gains 35% On Phase 3 Trial Update
Article By: BioMedReports
Tuesday, February 10, 2015 4:20 PM EDT
Anthera Pharmaceuticals Inc. (ANTH) jumped a whopping 35% to $3.53 this afternoon on huge volume of 13.04 million shares as the company announced that its Phase 3 trials will continue to completion as planned.
In this article: ANTH
Read
All Posts

Latest Tweets for $ANTH

No tweets yet!

PARTNER HEADLINES